跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,608 条关于
“KP-701”
全部
7,608
临床试验
2,770
药物
3,987
机构
11
资讯
840
2个月前
Jasper Therapeutics Merges with Kira Pharmaceuticals, Secures $132 Million to Advance Complement and Immunology Pipeline
2个月前
Mirador Therapeutics Licenses KP-301, a Long-Acting Anti-C5a Antibody, Expanding into ANCA-Associated Vasculitis
8个月前
KP.2 COVID-19 Vaccines Demonstrate Sustained 70% Effectiveness Over 12 Months in Major US Study
去年
FDA Approves Updated COVID-19 Vaccines Targeting Omicron KP.2 Strain for 2024-25 Season
2年前
Pfizer and BioNTech's Omicron KP.2-Adapted COVID-19 Vaccine Receives Positive CHMP Opinion
9个月前
BioMarin Awaits Pivotal INZ-701 Trial Results Following $270M Inozyme Acquisition
去年
Corbus Pharmaceuticals Presents Promising Phase 1 Data for Nectin-4 ADC CRB-701 at ASCO GU
去年
Inozyme's INZ-701 Shows Promise in ENPP1 Deficiency Trial with Sustained Phosphate Increases
9个月前
Terns Pharmaceuticals Closes $747.5 Million Public Offering to Advance BCR-ABL Inhibitor TERN-701
去年
Inozyme's INZ-701 Shows Promise in ENPP1 and ABCC6 Deficiencies
第 1 页,共 84 页
上一页
下一页